Abstract
Stroke is a major health problem and a leading cause of death and disability. Past research aimed to develop therapeutic strategies that prevent neuronal death and improve recovery. Yet, few successful therapeutic strategies have emerged. Recent findings demonstrated that the induction of the hypoxia signaling pathway of hypoxia-inducible factor (HIF) could mediate neuroprotective events. HIF-1 has been suggested to be an important player in neurological outcomes following ischemic stroke due to the functions of its downstream genes and implicated in both cellular protection and cell death in cerebral ischemia according to the duration and severity of ischemic injury. Therefore, HIF-1 has become an attractive target to counteract stroke. Here, we highlight the multifaceted role of HIF in stroke and some of the recently developed drugs that disrupt the HIF-1 signaling pathway which may provide potent leads for stroke therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
